Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to register for free online access

Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1087057108317145v1
13/5/378    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Zhang, X. D.
Right arrow Articles by Ferrer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, X. D.
Right arrow Articles by Ferrer, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Integrating Experimental and Analytic Approaches to Improve Data Quality in Genome-wide RNAi Screens

Xiaohua Douglas Zhang

Biometrics Research, Merck Research Laboratories, West Point, Pennsylvania, xiaohua_zhang{at}merck.com

Amy S. Espeseth

RNA Therapeutics, Merck Research Laboratories, West Point, Pennsylvania

Eric N. Johnson

Automated Biotechnology, Merck Research Laboratories, North Wales, Pennsylvania

Jayne Chin

Cardiovascular Diseases, Merck Research Laboratories, Rahway, New Jersey

Adam Gates

Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania

Lyndon J. Mitnaul

Cardiovascular Diseases, Merck Research Laboratories, Rahway, New Jersey

Shane D. Marine

Automated Biotechnology, Merck Research Laboratories, North Wales, Pennsylvania

Jenny Tian

Cardiovascular Diseases, Merck Research Laboratories, Rahway, New Jersey

Eric M. Stec

Automated Biotechnology, Merck Research Laboratories, North Wales, Pennsylvania

Priya Kunapuli

Automated Biotechnology, Merck Research Laboratories, North Wales, Pennsylvania

Dan J. Holder

Biometrics Research, Merck Research Laboratories, West Point, Pennsylvania

Joseph F. Heyse

BARDS, Merck Research Laboratories, West Point, Pennsylvania

Berta Strulovici

Automated Biotechnology, Merck Research Laboratories, North Wales, Pennsylvania

Marc Ferrer

Automated Biotechnology, Merck Research Laboratories, North Wales, Pennsylvania

RNA interference (RNAi) not only plays an important role in drug discovery but can also be developed directly into drugs. RNAi high-throughput screening (HTS) biotechnology allows us to conduct genome-wide RNAi research. A central challenge in genome-wide RNAi research is to integrate both experimental and computational approaches to obtain high quality RNAi HTS assays. Based on our daily practice in RNAi HTS experiments, we propose the implementation of 3 experimental and analytic processes to improve the quality of data from RNAi HTS biotechnology: (1) select effective biological controls; (2) adopt appropriate plate designs to display and/or adjust for systematic errors of measurement; and (3) use effective analytic metrics to assess data quality. The applications in 5 real RNAi HTS experiments demonstrate the effectiveness of integrating these processes to improve data quality. Due to the effectiveness in improving data quality in RNAi HTS experiments, the methods and guidelines contained in the 3 experimental and analytic processes are likely to have broad utility in genome-wide RNAi research. (Journal of Biomolecular Screening 2008:378-389)

Key Words: strictly standardized mean difference • Z factor • quality control • RNAi high-throughput screening • plate design

This version was published on June 1, 2008

Journal of Biomolecular Screening, Vol. 13, No. 5, 378-389 (2008)
DOI: 10.1177/1087057108317145


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BioinformaticsHome page
X. D. Zhang and J. F. Heyse
Determination of sample size in genome-scale RNAi screens
Bioinformatics, April 1, 2009; 25(7): 841 - 844.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
X. D. Zhang, S. D. Marine, and M. Ferrer
Error Rates and Powers in Genome-Scale RNAi Screens
J Biomol Screen, March 1, 2009; 14(3): 230 - 238.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
I. Coma, L. Clark, E. Diez, G. Harper, J. Herranz, G. Hofmann, M. Lennon, N. Richmond, M. Valmaseda, and R. Macarron
Process Validation and Screen Reproducibility in High-Throughput Screening
J Biomol Screen, January 1, 2009; 14(1): 66 - 76.
[Abstract] [PDF]


Home page
Nucleic Acids ResHome page
X. D. Zhang, P. F. Kuan, M. Ferrer, X. Shu, Y. C. Liu, A. T. Gates, P. Kunapuli, E. M. Stec, M. Xu, S. D. Marine, et al.
Hit selection with false discovery rate control in genome-scale RNAi screens
Nucleic Acids Res., August 1, 2008; 36(14): 4667 - 4679.
[Abstract] [Full Text] [PDF]